冷冻保存对献血者血浆ELISA和NAT检测结果稳定性的影响

张笑妍 ,  汪非凡 ,  赵子悦 ,  郭菲 ,  臧艳 ,  顾海慧 ,  查占山

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1218 -1222.

PDF (1989KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1218 -1222. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.09.008
论著

冷冻保存对献血者血浆ELISA和NAT检测结果稳定性的影响

作者信息 +

Effect of cryopreservation on the stability of ELISA and NAT results of donor plasma

Author information +
文章历史 +
PDF (2035K)

摘要

目的 考察经-80℃冷冻保存 2 个月的献血者血浆在 HBV、HCV、HIV 的 ELISA 检测与 NAT 中的稳定性,为边远地区及应急采血后标本的保存、运输及回溯性检测提供参考依据。方法 采用 3 组试验设计,每组试验均包括 ELISA(HBsAg、抗-HCV、HIV Ag-Ab)和 NAT(HBV DNA、HCV RNA、HIV-1 RNA)检测。稳定性验证试验:选取136份阳性和 150 份阴性献血者标本,于-80℃冻存 2 个月后使用原试剂复测,比较冻存前后 ELISA S/ CO 值及 NAT Ct值和检测结果符合率;最低检出限验证试验:将已知浓度的标准品稀释为 3 种梯度的弱反应性标本(ELISA S/ CO 值为 0. 8-5,NAT Ct 值为 35-42),冻存前后各检测 6 次取平均值,比较冻存前后 ELISA S/ CO 值和 NAT Ct 值;真实世界验证试验:随机选取 300 份献血者标本,于初测后分离血浆并冷冻保存 2 个月,比较冻存前后 ELISA 与 NAT 的反应性检出率。结果 稳定性验证试验:ELISA 试验中,3 份标本弱阳转阴性、3 份标本弱阳转灰区,检测结果符合率97. 9%;NAT 试验中,2 份标本弱阳转灰区,检测结果符合率 99. 30%。冻存后 ELISA S/ CO 值和 NAT Ct 值均有差异(P<0. 05);最低检出限验证试验:3 种浓度的弱反应性标本冻存前后 ELISA S/ CO 值和 NAT Ct 值均无差异(P>0. 05),仅 0. 5 NCU/ mL 标本抗-HCV ELISA 结果由阳性转为灰区;真实世界验证试验:标本冻存前后 ELISA 反应性检出率为 1. 67% vs 1. 00%,NAT 反应性检出率为 0. 33% vs 0. 33%,均无差异(P≥0. 05)。结论 献血者血浆经-80℃冷冻保存 2 个月后,ELISA 及 NAT 检测的总符合率极高,尽管弱阳性标本易受冷冻影响,但总体定性结果稳定,证明深低温冻存可有效维持病毒标志物的检测稳定性。

Abstract

Objective To investigate the stability of plasma from blood donors cryopreserved at -80℃ for two months in ELISA and NAT detection (HBV, HCV, and HIV), and to provide a reference for the preservation, transportation, and retrospective testing of samples collected in remote areas or during emergency blood collection. Methods Three sets of experimental designs were adopted, each including ELISA (HBsAg, anti-HCV, HIV Ag-Ab) and NAT (HBV DNA, HCV RNA, HIV-1 RNA) testing. Stability validation test: 136 positive and 150 negative donor samples were selected, retested with the original reagents after cryopreservation at -80℃ for two months, and the ELISA S/ CO values, NAT Ct values, and result concordance rates before and after freezing were compared. Limit of detection validation test: Standard substances with known concentrations were diluted into three gradients of weakly reactive samples (ELISA S/ CO values of 0. 8-5, NAT Ct values of 35-42). Each was tested six times before and after freezing, the mean values were calculated, and the ELISA S/ CO values and NAT Ct values were compared. Real-world validation test: 300 randomly selected donor samples were subjected to plasma separation after initial testing and cryopreserved for two months. The reactive detection rates of ELISA and NAT before and after freezing were compared. Results Stability validation test: In ELISA testing, 3 samples converted from weak-positive to negative, and 3 samples converted from weak-positive to gray zone, yielding a concordance rate of 97. 9%. In NAT testing, 2 samples converted from weak-positive to gray zone, yielding a concordance rate of 99. 30%. Significant differences were observed in both ELISA S/ CO values and NAT Ct values after freezing (P<0. 05). Limit of detection validation test: No significant differences were found in ELISA S/ CO values or NAT Ct values for the three concentrations of weakly reactive samples before and after freezing (P>0. 05); only the anti-HCV ELISA result for the 0. 5 NCU/ mL sample converted from positive to the gray zone. Real-world validation test:The ELISA reactive detection rates before and after freezing were 1. 67% vs 1. 00%, and the NAT reactive detection rates were 0. 33% vs 0. 33%, with no significant differences (P≥0. 05). Conclusion After cryopreservation of donor plasma at -80℃ for two months, the overall concordance rates for ELISA and NAT testing are extremely high. Although weak-positive samples are susceptible to freezing effects, the overall qualitative results remain stable, demonstrating that deep-low temperature cryopreservation can effectively maintain the stability of viral marker detection.

关键词

深低温冻存 / 酶联免疫吸附试验(ELISA) / 核酸检测(NAT) / 血液安全 / 灰区

Key words

deep cryopreservation / enzyme-linked immunosorbent assay (ELISA) / nucleic acid testing (NAT) / blood safety / grey zone

引用本文

引用格式 ▾
张笑妍,汪非凡,赵子悦,郭菲,臧艳,顾海慧,查占山. 冷冻保存对献血者血浆ELISA和NAT检测结果稳定性的影响[J]. 中国输血杂志, 2026, 39(9): 1218-1222 DOI:10.13303/j.cjbt.issn.1004-549x.2026.09.008

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

国家卫生健康委员会. 血站技术操作规程(2019 版):国卫医函〔2019〕98 号附件[S].2019.

[2]

National Health Commission of the PRC. Technical operating procedures for blood stations (2019 Edition):Notification Guo Wei Yi Han〔2019〕98[S].2019.

[3]

刘静,陈岩. 冰冻核酸标本质量控制对检测结果的影响[J].黑龙江医药科学,2020,43(5): 64-66.

[4]

LIU J, CHEN Y. Impact of freeze-thaw quality control of nucleic acid specimens on test results[J].Heilongjiang Medicine and Pharmacy, 2020,43(5): 64-66.

[5]

张连阳,李阳. 大出血的损害控制性复苏-挽救战伤伤员的关键[J].解放军医学杂志,2017,42(12):1025-1028.

[6]

ZHANG L Y, LI Y. Damage control resuscitation of massive hemorrhage: The key to saving the combat casualties[J].Med J Chin PLA, 2017,42(12):1025-1028.

[7]

FDA. Use of nucleic acid tests on pooled and individual samples from donors of whole blood and blood components, including source plasma, to reduce the risk of transmission of hepatitis B virus: guidance for industry[EB/OL].(2012-10)[2025-09-19]. https://www.fda.gov/media/124225/download.

[8]

ANDREASSON A, KISS N B, JUHLIN C C, et al. Long-term storage of endocrine tissues at -80℃ does not adversely affect RNA quality or overall histomorphology[J].Biopreserv Biobank,2013,11(6):366-370.

[9]

BALERIOLA C, JOHAL H, JACKA B, et al. Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at-20℃ and -70℃[J].J Clin Microbiol,2011,49 (9):3163-3167.

[10]

连斯敏,陈晓华,林树波,等. 长期冷冻对 ELISA 法检测血浆标本中 HBsAg 结果的影响[J].中国输血杂志, 2024,37(1):91-94.

[11]

LIAN S M, CHEN X H, LIN S B, et al. Effect of long-term frozen plasma on the detection of HBsAg by ELISA[J].Chin J Blood Transfusion, 2024, 37(1): 91-94.

[12]

陈洪生,陈佳微,张三明,等. ELISA“灰区” 范围的设定对献血者血液检测安全和血源保护的意义[J].中国输血杂志,2015,28(9): 1140-1141.

[13]

CHEN H S, CHEN J W, ZHANG S M, et al. Significance of setting the ELISA “ gray zone” range for blood donation safety and donor protection[J].Chin J Blood Transfusion, 2015,28(9): 1140-1141.

[14]

金建怀,许友山,蒋瑞馨,等. 血筛实验室 HBsAg 酶联免疫吸附试验灰区设置分析[J].中国输血杂志,2021,34(1):74-77.

[15]

JIN J H, XU Y S, JIANG R X, et al. The grey area of HBsAg enzyme-linked immunosorbent assay (ELISA) in blood screening laboratory[J].Chin J Blood Transfusion, 2021, 34(1): 74-77.

[16]

黎锦,李一荣. 内源性抗体对临床免疫检测的干扰及对策[J].中华检验医学杂志,2016,39(11):811-813.

[17]

LI R, LI Y R. Interference of endogenous antibody in clinical immunoassay and its countermeasure[J].Chin J Lab Med, 2016,39(11):811-813.

[18]

刘香萍,汪小娟,李碧云. 乙型肝炎病毒表面抗原弱反应性标本的确认与分析[J].检验医学与临床,2009,6(22):1899-1900.

[19]

LIU X P, WANG X J, LI B Y. Confirmation and analysis of weak reactive hepatitis B surface antigen[J].Lab Med Clin,2009,6(22):1899-1900.

[20]

JOSE M, RODRIGD G, JUAN J. Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples under long-term storage[J].Biologicals,2005,33(1): 9-16.

[21]

WANG Y P, YANG S W, JIA F, et al. Effect of concentration, temperature, and time on the stability of hepatitis C virus nucleic acid in serum[J].Microbiol Spectr,2024,12(10):e0076924.

[22]

KRAJDEN M, MINOR J M, RIFKIN O, et al. Effect of multiple freeze-thaw cycles on hepatitis B virus DNA and hepatitis C virus RNA quantification as measured with branched-DNA technology[J].J Clin Microbiol,1999,37(6):1683-1686.

[23]

尹云弟,李玲,孙玉娟,等. 不同储存条件和时间对HCV RNA 检测结果的影响[J].中国输血杂志,2018,31(6):613-616.

[24]

YIN Y D, LI L, SUN Y J, et al. The effects of different storage conditions and testing time on the result of HCV RNA testing[J].Chin J Blood Transfusion, 2018, 31(6): 613-616.

[25]

江雅平,李智慧,李志艳,等. 不同保存条件及反复冻融对血清 HCV 抗体检测的影响[J].检验医学,2021,36(10):1060-1063.

[26]

JIANG Y P, LI Z H, LI Z Y, et al. Effects of different storage conditions and repeated freeze-thaw cycles on the detection of serum HCV antibodies[J].Lab Med,2021,36(10):1060-1063.

基金资助

十四五海军国防应用推进计划(145BKJ050204000X)

AI Summary AI Mindmap
PDF (1989KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉